Searchable abstracts of presentations at key conferences in endocrinology

ea0022p55 | Adrenal | ECE2010

Influence of various clinical variables and storage conditions on urinary cortisol levels: gas chromatography–mass spectrometry (GC–MS) versus immunoassay

Deutschbein Timo , Broecker-Preuss Martina , Hartmann Michaela , Wudy Stefan , Althoff Ricarda , Mann Klaus , Petersenn Stephan

Introduction: Measurement of urinary cortisol is often used to assess disease activity in patients with suspected or proven hypercortisolism. However, specific reference ranges are lacking for some of the newer assays. This study analyzed upper limits of normal (ULN, mean+2S.D.) for two analytical procedures (GC–MS, ECLIA) in relation to various independent variables. Besides, the influence of different storage conditions was investigated (by ECLIA).<p ...

ea0022p396 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Outcome of two chemotherapies in the treatment of progressive, undifferentiated neuroendocrine carcinomas: a single-center experience

Deutschbein Timo , Unger Nicole , Yuece Ali , Lahner Harald , Mann Klaus , Petersenn Stephan

Introduction: Treatment of poorly differentiated neuroendocrine tumors (NET) usually includes chemotherapeutic intervention. However, both the rarity and the heterogeneity of the disease have led to relatively few clinical trials. This study evaluated the outcome of two chemotherapy regimens in patients suffering from undifferentiated and histologically confirmed NET.Methods: Eighteen patients (11 males; age 56.7±2.5) with proven progressive disease...

ea0020p24 | Adrenal | ECE2009

Characterization of tyrosine hydroxylase expression in various adrenal tumors to confirm the diagnosis of adrenal pheochromocytomas

Ueberberg Bianca , Hinrichs Jakob , Walz Martin K , Schmid Kurt W , Mann Klaus , Petersenn Stephan

Background: Tyrosine hydroxylase (TH) is the first enzyme in the pathway of catecholamine synthesis catalyzing the conversion of tyrosine to dihydroxyphenylalanine (DOPA). To establish a molecular marker for adrenal pheochromocytomas, we compared the expression in various adrenal tumors in comparison to normal adrenal glands.Methods: Tissue from 19 pheochromocytomas (PHEO), 20 aldosterone-producing adenomas (APA), 20 cortisol-producing adenomas (CPA), an...

ea0020p594 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR

Schopohl Jochen , Badenhoop Klaus , Beuschlein Felix , Droste Michael , Plockinger Ursula , Petersenn Stephan , Strasburger Christian

Acromegalic patients under treatment with Octreotide LAR (Oct), 10, 20 or 30 mg were switched to Lanreotide Autogel 120 mg (Lan) at different dose intervals: 56, 42 and 28 days respectively. Just before the fourth Lan injection, IGF-I values were measured and the dose interval for the final three injections adjusted accordingly: if IGF-I values were between 1 and 2 standard deviations (S.D.) above the age and sex related mean value, no change in dose-interval wa...

ea0016p476 | Neuroendocrinology | ECE2008

Prospective comparison of the glucagon stimulation test (GST) with the insulin tolerance test (ITT) in patients following pituitary surgery

Berg Christian , Meinel Timo , Yuece Ali , Lahner Harald , Mann Klaus , Petersenn Stephan

Objective: The ITT is the gold-standard for assessment of GH and ACTH reserve but has certain contraindications. GH and cortisol responses of <3 ng/ml and <500 nmol/l, respectively, have been defined as evidence of severe deficiency. The GST like the ITT stimulates both the ACTH and GH secretion and is suggested to be a good alternative in terms of efficiacy. However, there are limited prospective data with modern assays on sensitivity and specificity for the GST in co...

ea0014p138 | (1) | ECE2007

Initial presentation of patients with acromegaly - analysis of the German acromegaly register

Petersenn Stephan , Reincke Martin , Buchfelder Michael , Franz Holger , Quabbe Hans-Jürgen

Due to its rarity, initial endocrine abnormalities in acromegaly are difficult to investigate in a large cohort, especially with respect to cofounding variables. We searched the German Acromegaly Register for data on the first presentation of patients with acromegaly.Up to November 2005, 1485 patients with acromegaly had been entered into the database. Male patients demonstrated significantly higher random GH (21.0 (0.2–620.0) ng/ml, median (range))...

ea0014p174 | (1) | ECE2007

Evaluation of plasma and urinary metanephrines as well as serum chromogranin A for the diagnosis of pheochromocytoma

Unger Nicole , Pitt Christian , Walz Martin K , Mann Klaus , Petersenn Stephan

Adrenal pheochromocytomas are neoplasms characterized by catecholamine excess. We recently reported on the diagnostic value of plasma metanephrines measured by RIA for the diagnosis of pheochromocytoma. However, RIA may not be used in many laboratories.This study evaluated plasma and urinary metanephrines determined by a newly available ELISA as well as serum chromogranin A (CgA) for the diagnosis of pheochromocytoma. Spontaneous blood samples and 24h-ur...

ea0041ep609 | Endocrine tumours and neoplasia | ECE2016

Craniopharyngioma registry for adult patients, an initiative of the pituitary workgroup of the DGE

Mende Klaus Christian , Kopczak Anna , Deutschbein Timo , Droste Michael , Honegger Jurgen , Stalla Gunther , Muller Herrmann , Petersenn Stephan , Flitsch Jorg

Introduction and Objective: Adult craniopharyngioma as a rare neoplasm of the central nervous system is still very poorly understood. The clinical implications for affected patients are numerous, ranging from endocrine dysfunction to visual loss and neurological impairment. Although the progress of this tumor entity is slow by nature, affected patients often suffer from multiple symptoms even after successful treatment with a strong impact on their individual quality of life. ...

ea0032p853 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Evaluation of late-night salivary cortisol during a Phase III study with pasireotide in patients with Cushing's disease

Newell-Price John , Petersenn Stephan , Pivonello Rosario , Findling James , Fleseriu Maria , Trovato Andrew , Hughes Gareth , Ligueros-Saylan Monica , Biller Beverly

Introduction: Generously supported by IPSEN)-->Measurement of salivary cortisol is a simple, convenient, accurate and reproducible technique with potential value during the diagnosis/management of hypercortisolism. Current analysis evaluates changes in late-night salivary cortisol (LNSC) during pasireotide treatment in patients with Cushing’s disease (CD).Methods: A 12 m, Phase III study enrolled 162 adult...

ea0016p44 | Adrenal | ECE2008

Quantitative real time RT-PCR of CYP11B2 (aldosterone synthase) to confirm the diagnosis of aldosterone-producing adenomas

Ueberberg Bianca , Althoff Ricarda , Deutschbein Timo , Unger Nicole , Hinrichs Jakob , Walz Martin K , Schmid Kurt W , Petersenn Stephan

Background: The diagnosis of hyperaldosteronism is hindered by the absence of a well-defined gold-standard. CYP11B2 (aldosterone synthase) belongs to the steroid-metabolizing enzymes catalyzing the last step of the aldosterone synthesis. To establish a molecular marker for aldosterone-producing adenomas, we compared the expression in various adrenal tumors.Methods: Tissue from 20 aldosterone-producing adenomas (APA), 12 hyperplasias associated with hyper...